Company Search:
Advanced Search
Sponsored Links
Akcea Therapeutics Inc Company Snapshot
Akcea Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Akcea Therapeutics Inc with three other companies in this sector in the United States: Lexicon Pharmaceuticals Incorporated (2018 sales of $63.21 million of which 100% was Pharmaceutical R&D), Spring Pharmaceutical Group Inc ($64.94 million ), and Vivus, Inc. ($65.06 million of which 100% was Therapeutic Systems).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Akcea Therapeutics Inc
  Stock Performance Chart for Akcea Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 19.31
(Figures in U.S. Dollars)
1 Week 0.0%   13 Weeks 6.8%  
4 Weeks -9.3%   52 Weeks -35.6%  
Akcea Therapeutics Inc Key Data:
  Ticker: AKCA Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 64,867,000
(Year Ending Jan 2019).
Employees: 248
  Currency: U.S. Dollars Market Cap: 1,812,927,344
  Fiscal Yr Ends: December Shares Outstanding: 93,885,414
  Share Type: Common Closely Held Shares: 76,534,923
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.